Brain microvascular endothelial cells exhibit lower activation of the alternative complement pathway than glomerular microvascular endothelial cells

The Complement Anaphylatoxins C5a and C3a Suppress IFN-β Production in Response toListeria monocytogenesby Inhibition of the Cyclic Dinucleotide–Activated Cytosolic Surveillance Pathway

(2017) Stacey L. Mueller-Ortiz et al.   JOURNAL OF IMMUNOLOGY

Characterization of the Regulation ofCD46RNA Alternative Splicing

(2016) Sze Jing Tang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Expression of anaphylatoxin receptors on platelets in patients with coronary heart disease

(2015) J. Patzelt et al.   ATHEROSCLEROSIS

Complement in hemolytic anemia

(2015) R. A. Brodsky   BLOOD

Eculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS

(2015) R. Cofiell et al.   BLOOD

The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy

(2015) S. Jodele et al.   BLOOD

A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury

(2015) Sonata Jodele et al.   BLOOD REVIEWS

TNF Regulates Essential Alternative Complement Pathway Components and Impairs Activation of Protein C in Human Glomerular Endothelial Cells

(2015) Sarah E. Sartain et al.   JOURNAL OF IMMUNOLOGY

The Receptor for the Complement C3a Anaphylatoxin (C3aR) Provides Host Protection against Listeria monocytogenes-Induced Apoptosis

(2014) S. L. Mueller-Ortiz et al.   JOURNAL OF IMMUNOLOGY

C3a Receptor Antagonist Ameliorates Inflammatory and Fibrotic Signals in Type 2 Diabetic Nephropathy by Suppressing the Activation of TGF-β/smad3 and IKBα Pathway

(2014) Ling Li et al.   PLoS One

Insights From the Use in Clinical Practice of Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome Affecting the Native Kidneys: An Analysis of 19 Cases

(2013) Fadi Fakhouri et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy

(2013) S. Jodele et al.   BLOOD

Complement activation in diseases presenting with thrombotic microangiopathy

(2013) Seppo Meri   European Journal of Internal Medicine

C3a, C5a Renal Expression and Their Receptors are Correlated to Severity of IgA Nephropathy

(2013) Lu Liu et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Complement Activation Associated with ADAMTS13 Deficiency in Human and Murine Thrombotic Microangiopathy

(2013) R. Tati et al.   JOURNAL OF IMMUNOLOGY

Assembly and Activation of Alternative Complement Components on Endothelial Cell-Anchored Ultra-Large Von Willebrand Factor Links Complement and Hemostasis-Thrombosis

(2013) Nancy A. Turner et al.   PLoS One

The Interaction between Factor H and Von Willebrand Factor

(2013) Shuju Feng et al.   PLoS One

C3a and C5a Promote Renal Ischemia-Reperfusion Injury

(2012) Q. Peng et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy

(2011) B. L. Laskin et al.   BLOOD

Atypical hemolytic uremic syndrome

(2011) Chantal Loirat et al.   Orphanet Journal of Rare Diseases

Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome

(2010) Tara K. Maga et al.   HUMAN MUTATION

Transplant-associated thrombotic microangiopathy in pediatric patients treated with sirolimus and tacrolimus

(2010) Joseph Rosenthal et al.   PEDIATRIC BLOOD & CANCER

The internal thioester and the covalent binding properties of the complement proteins C3 and C4

(2010) S. K. Alex Law et al.   PROTEIN SCIENCE

Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning

(2009) E Willems et al.   BONE MARROW TRANSPLANTATION

The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments

(2009) S. A. Bustin et al.   CLINICAL CHEMISTRY

Renal Thrombotic Microangiopathy after Hematopoietic Cell Transplant: Role of GVHD in Pathogenesis

(2009) S. Changsirikulchai et al.   Clinical Journal of the American Society of Nephrology

The role of the anaphylatoxins in health and disease

(2009) Andreas Klos et al.   MOLECULAR IMMUNOLOGY

Thrombomodulin Mutations in Atypical Hemolytic–Uremic Syndrome

(2009) Mieke Delvaeye et al.   NEW ENGLAND JOURNAL OF MEDICINE

Thrombotic Microangiopathy After Allogeneic Hematopoietic Stem Cell Transplantation: An Autopsy Study

(2009) Koushan Siami et al.   TRANSPLANTATION

Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome

(2008) V. Fremeaux-Bacchi et al.   BLOOD

Complement and the atypical hemolytic uremic syndrome in children

(2008) Chantal Loirat et al.   PEDIATRIC NEPHROLOGY

Discrimination between host and pathogens by the complement system

(2008) Michael K. Pangburn et al.   VACCINE